Recap: KLA Q4 Earnings

KLA (NASDAQ:KLAC) reported its Q4 earnings results on Thursday, July 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings KLA beat estimated earnings by 5.64%, reporting an EPS of $5.81 versus an estimate of $5.5.

KLA (NASDAQ:KLAC) reported its Q4 earnings results on Thursday, July 28, 2022 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

KLA beat estimated earnings by 5.64%, reporting an EPS of $5.81 versus an estimate of $5.5.

Revenue was up $562.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.31 which was followed by a 4.06% drop in the share price the next day.

Here’s a look at KLA’s past performance:

 

Quarter Q3 2022 Q2 2022 Q1 2022 Q4 2021
EPS Estimate 4.82 5.44 4.52 3.99
EPS Actual 5.13 5.59 4.64 4.43
Revenue Estimate 2.20B 2.33B 2.04B 1.87B
Revenue Actual 2.29B 2.35B 2.08B 1.93B

To track all earnings releases for KLA visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Earnings Outlook For UroGen Pharma

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma will report an earnings per share (EPS) of $-1.17.

URGN